|
||||||||||||||||||||||||||||||||||||||
|
|
WCTF.org Transplant NewsTransplant news, links, and other general medical news -- updated regularly.Wednesday, April 16, 2008AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes (Marketwire via Yahoo! Finance)
AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes (Marketwire via Yahoo! Finance)
AtheroGenics, Inc., a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today released topline results from a planned interim analysis of its ongoing ANDES Phase 3 clinical trial of AGI-1067 for the treatment of Type 2 diabetes. ArchivesMar 21, 2008 Mar 22, 2008 Mar 23, 2008 Mar 24, 2008 Mar 25, 2008 Mar 26, 2008 Mar 27, 2008 Mar 28, 2008 Mar 29, 2008 Mar 30, 2008 Mar 31, 2008 Apr 1, 2008 Apr 2, 2008 Apr 3, 2008 Apr 4, 2008 Apr 5, 2008 Apr 6, 2008 Apr 7, 2008 Apr 8, 2008 Apr 9, 2008 Apr 10, 2008 Apr 11, 2008 Apr 12, 2008 Apr 13, 2008 Apr 14, 2008 Apr 15, 2008 Apr 16, 2008 Subscribe to Posts [Atom] |
|
| |||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||
